Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What some here refuse to consider is that the delays are on purpose. The desire to not run trials they know will be futile is apparent. Don't blame the Doctors or the CRO's they are in business to run trials that a customer presents to them and were willing to do so. KW is just running the clock out until retirement and then person X will take over and explain how they have reorganized and because the cost is prohibitive they have decided to focus on diabetes because that will bring the most value to shareholders. Longs will cheer that now that KW is gone we are focused just like the countless times they have bought this BS before. KW will gladly be the $6,000,000.00 scapegoat like the shady management before him. Change the name to Melligencyte and start all over. IMHO
Unless the $6 million dollar man KW puts out a PR saying IND has been filed and clinical trial sites are preparing why put out a PR? There is no future date he could possibly release that anyone but the true lifers would believe.
$6,026,252.00 KW's pay since Jan 2014 thru April 2017.
Try looking on the company FB page.
So is the year 3020 but none of us will be around to see it. Maybe Kenny's Great Great Great grandson will announce IND. Until one patient is dosed with PMCB's treatment this company is what it has always been a stock selling company. How many people who post on this board have been saying the same thing about kaboom and soon for 15 years.
Are these the kind of stories the Hollywood Agent is going to tell?
SILVER SPRING, MD, March 27, 2015 (GLOBE NEWSWIRE) – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that the genetically modified cells that are required for its three planned clinical trials have been fully tested and are in the process of being propagated to produce all of the cells necessary for the clinical trials.
The cells being produced came from a fully characterized single-cell clone of the cells that were used in the previous clinical trials in pancreatic cancer. These cells are being grown under conditions that comply with current Good Manufacturing Practices (cGMP) standards.
What has PMCB done to justify a higher PPS?
What story is there to tell? The company has a technology that was developed 20 years ago and has owned it and done nothing with it for 5+ years. What story do you tell about a technology that has proven nothing. Biotech's that hire people to tell stories are not biotech's they are stock selling companies. Results get published and attract investors.
Biotech don't need to hire people to tell stories. Any real positive news sends biotech stocks soaring. Scam companies hire people to tell stories because they have no real news.
There is no update because the news is not "rosy". Kenny is churning his lawyer brain looking for a good spin. If there was good news the company would be pumping out PR twice a week.
LOL its shared office space not a headquarters . PMCB has no "headquarters" No research facility Not even any furniture.
No I am saying this treatment is silly. Treating PC the way Pharmacyte proposes is silly.
Watch the series of videos on YouTube and you will realize how complex the treatment of pancreatic cancer is and how silly the idea of CIAB is.
Telling stories instead of producing results is what efood saftey/ Nuvilex and now Pharmacyte has always been about. What biotech hires a Hollywood agent to tell stories? One that has nothing show.
He is not wasting any of his time. What do you think board members of PMCB do? They don't vote on anything KW does whatever he wants to. All the board members for PMCB do is collect their $12,500 a quarter and their free shares every year.
LOL. Still running with the Jensen angle is hysterical. As much as I would love CIAB to actually get to a clinical trial so this gimmick technology could finally be proven to be the joke it is I would hate to see someone elect to try it and not be helped. There are so many promising treatments such as Von Hoff's triple treatment and many new immunotherapies for PC very close to reporting mid-stage results. What Doctor would steer a patient to CIAB?
What biotech has ever been successful targeting the Chinese market? China controls their marketplace and only allows their own interests to be successful. But most know this is only another diversion from the fact that CIAB and PMCB are nothing but a platform to sell shares and pay management. The total lack interest in this company from the average and institutional investor proves this stock is only for trading and those who refuse to realize that CIAB is a gimmick technology being used to enrich management.
You shut down the "scam" narrative how? The complexity of the organization? You must be joking because the organization is basically Kenny his sidekick Carlos and a retired Dr. Crabtree. Every other person PMCB has associated with them all are full time employees of other companies or Hospitals. By the way this is common practice for Dr's to basically sell their name to various companies in return for pay. Take Dr. Manuel Hidalgo for example. Dr. Manuel Hidalgo oversees all Beth Israel Deaconess Medical Center clinical cancer programs. He is also affiliated with all of these other companies.
Aclara Biosciences Inc.
Monogram Biosciences, Inc.
Universidad Autónoma de Madrid
Facultad de Medicina de la Universidad de Navarra
Targeted Molecular Diagnostics, LLC
Cavion LLC
MedTrust Online, LLC
Sun BioPharma, Inc.
VCN Biosciences SL
Oncomatryx Biopharma, S.A.
Maybe you should take another shot at explaining the sheer complexity of the organization that bought a treatment 5 years ago that had already been in clinical trials with data and results published yet can't seem to be able to file an IND for a trial that was suppose to start 4 years ago. A company that has spent $40,000,000 in those four years with less then 10% on R&D (and the R&D spend was for rights not research)
Don't worry Shady Kenny will be updating everyone from his house in the Hampton's or wherever he is on vacation this month. He will tell you that they are all working really really hard and they only get one shot at this. I'm not sure what "this" is but whatever it is they one get one shot. NDA's are signed we are talking with potential investors. Blah Blah Blah. In other words i will just replay the last CC.
Difference is Tesla had strong financial backing and a competent management team and strategy. PMCB on the other hand has flat out lied to investors about being able to conduct clinical trials in 2014,2015 and 2016 seeing how their partner Austrianova could not even produce CIAB because they had no facility built. But that didn't stop PMCB from issuing paid PR over and over about trials starting. Go to their website and read all of their release from years ago thru today. ALL BS.
LOL I don't know what you call a Big Red flag but if you have been following this company for any length of time you would know its just one huge red flag. ZERO accomplishments in forever. A biotech company that has as its main employees a 70 year old lawyer and his buddy a bookkeeper. No physical location. A technology that has been around for 20+ years with zero interest.
The only thing this stock is good for is trading. The red flags are small? Promising clinical trials in 2014,2015,2016 and 2017 and not even being able to file an IND in five years. $40,000,000 spent in the past 5 years on management salary's and freebies for friends and stock promotion.
Its amazing how many years someone can speculate on a company and yet nothing ever happens. efood/nuvilex/pharmacyte. Must be going on two decades by now.
It sure got the faithful to stop talking about the total lack of any progress from shady Kenny.
We have a company that can't file an IND in the five years they have owned CIAB and there is going to be a bidding war on what exactly? They don't even own furniture.
The writing is come aboard the PMCB free money train. Get paid for not working we only need your name.
I just gave you some facts. But facts are not what most want to read. Most want to dream that a shady lawyer with no biotech experience is going to cure cancer and diabetes out of his shared office space while hiring random people as consultants and spending nothing or R&D.
Some facts about where this company was when shady Kenny took over PMCB. There were 602,958,014 shares outstanding and they had an Accumulated deficit of $52,229,316. Now there is 973,167,811 shares outstanding and an Accumulated deficit of $90,823,717. So shady Kenny has issued 370,209,797 shares and spent $38,594,401. Beside the $4 million or so given yo Austrianova for rights to CIAB where did all this money go? Pmcb has no buildings or labs. They have not invented anything new that cost $Millions. I bet you all really know where all this money went and continues to go and i bet you really know that no credible company would ever invest in a company whose primary goal is obviously NOT to help people with cancer or any other medical condition.
The truth is that this company has done nothing so what contribution can anyone make to nothing? One can only comment on what one sees. PMCB/Nuvilex/EFood saftey. 20 years of nothing. IMHO
Every time PMCB appoints someone the same old BS is posted that this person is going to make X happen and not one of them has contributed anything. The guy is going to collect his $12,500.00 a qtr. and you will never hear another word about him just like everyone else the appoint.
Not one of these so called great people PMCB has affiliated with them has invested a penny in the company. In fact all of them have been sucking money out of the company. Gee i wonder why that is?
Our Asia strategy. LOL !! How about a file an IND strategy. Just more stupid appointments of people that contribute nothing but collect $$ and give Kenny an excuse to issue a PR about how person X will open up investors to PMCB blah blah blah....
Another useless PR. Another mouth to feed 50k a year plus 500,0000 free shares a year.
An update in Oct. Submit questions. Why not just issue a press release update now? Does anyone believe the company does not know exactly what its shareholders want to know? Just another delay tactic to try and put together some spin.
How would you possibly know what the company is doing or waiting for? Because people are guessing. For all anyone knows they could have done little or nothing since the last CC. Why would a company like PMCB that has done nothing but release hyped up PR for the last 5 + years all on a sudden not promote their achievements? Oh ya i forgot the fake NDA's and partnerships. LOL
Never seen a real biotech company that has no full time employee for Regulatory Affairs, Chief Medical Officer or R+D. PMCB is far more interested in employing a Lawyer, CPA and a retired old Crabtree. Lots of consultants that have full time + jobs and spend zero time working for PMCB but get paid for their name. They are really good at selling shares and paying their shady management $ Millions $ though.
Let's see how many "real" questions shady Kenny answers in his update as i am sure many tough questions were submitted. My guess is ZERO.
The call will start out with 20 min of Kenny describing CIAB and how it works for all of the "new" shareholders. By the time he starts answering his own fluffy questions 90% of listeners will be nodded off or banging their heads off their desk. Then the "longs" will come on here and proclaim what good hands we are in and post a list of all the "accomplishments" he has made in the past five years.
Fast forward 6 months and repeat..........
He didn't have to Kenny boy has been on vacation for 4+ years now. And he never even thanked you for paying for it.
Actually KW was in Canada with his wife on vacation as usual. But of course why let the truth get in the way of wild speculation. IMHO.
Five years without a clinical trial for a product that was already in clinical trials is not slow-casino. Collecting $millios in compensation during those five years while doubling the share count is not slow-casino its called scamming your shareholders. IMHO